Cullinan Therapeutics, Inc. - CGEM

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$970.4M

QoQ value delta ($000)

+$312.9M (+47.59%)

Implied price effect (QoQ)

+35.39%

Total shares

69,277,757

QoQ shares delta

+5,728,426 (+9.01%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 173 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Lynx1 Capital Management LP	127,371	8,963,500	20.13%
MPM BioImpact LLC	108,681	7,648,268	8.39%
BVF INC/IL	81,717	5,750,683	2.6%
BlackRock, Inc.	63,234	4,449,966	0.0%
Kynam Capital Management, LP	44,251	3,114,132	2.73%
STATE STREET CORP	36,151	2,544,115	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	35,283	2,483,034	0.0%
VANGUARD GROUP INC	34,139	3,298,504	0.0%
PRICE T ROWE ASSOCIATES INC /MD/	28,843	2,029,719	0.0%
Blue Owl Capital Holdings LP	27,137	1,909,764	7.29%
RTW INVESTMENTS, LP	24,241	1,705,960	0.24%
Venrock Adviser, LLC	19,609	1,379,965	0.73%
GEODE CAPITAL MANAGEMENT, LLC	19,447	1,368,268	0.0%
Siren, L.L.C.	16,958	1,193,410	0.47%
Nextech Invest, Ltd.	16,215	1,141,145	1.14%
BOOTHBAY FUND MANAGEMENT, LLC	15,812	1,112,803	0.2%
MARSHALL WACE, LLP	14,914	1,049,581	0.01%
DIMENSIONAL FUND ADVISORS LP	12,870	906,028	0.0%
Point72 Asset Management, L.P.	12,865	905,376	0.02%
Nuveen, LLC	11,448	805,700	0.0%
Affinity Asset Advisors, LLC	11,101	781,260	0.57%
TWIN FOCUS CAPITAL PARTNERS, LLC	8,461	595,489	0.97%
MORGAN STANLEY	8,376	589,483	0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC	7,851	552,553	0.0%
Elmind Capital, LP	7,531	530,000	2.14%